Lisdexamfetamine Dimesylate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 64850-556
  • Package NDC 64850-556-01
  • Application number ANDA218604
  • SPL ID 2d33f701-8067-4a48-98cc-4e7dacaf3cc4
  • SPL set ID 0e024b69-567c-4b40-9c3e-a2daec34256c
  • UNII SJT761GEGS
  • RxCUI 854830
  • RxCUI 854834
  • RxCUI 854838
  • RxCUI 854842
  • RxCUI 854846
  • RxCUI 854850
  • RxCUI 1593856

What the source publishes

Labeler
Elite Laboratories, Inc.
Active ingredients
lisdexamfetamine dimesylate
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:64850-556_2d33f701-8067-4a48-98cc-4e7dacaf3cc4
{
  "name": "Lisdexamfetamine Dimesylate",
  "splId": "2d33f701-8067-4a48-98cc-4e7dacaf3cc4",
  "labels": [
    {
      "setId": "0e024b69-567c-4b40-9c3e-a2daec34256c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e024b69-567c-4b40-9c3e-a2daec34256c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0e024b69-567c-4b40-9c3e-a2daec34256c"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Elite Laboratories, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (64850-556-01)",
      "package_ndc": "64850-556-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241115"
    }
  ],
  "productId": "64850-556_2d33f701-8067-4a48-98cc-4e7dacaf3cc4",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "64850-556",
  "deaSchedule": "CII",
  "genericName": "lisdexamfetamine dimesylate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LISDEXAMFETAMINE DIMESYLATE",
      "strength": "70 mg/1"
    }
  ],
  "applicationNumber": "ANDA218604",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20241115",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0364850552011",
      "0364850550017",
      "0364850553018",
      "0364850556019",
      "0364850555012",
      "0364850551014",
      "0364850554015"
    ],
    "unii": [
      "SJT761GEGS"
    ],
    "rxcui": [
      "854830",
      "854834",
      "854838",
      "854842",
      "854846",
      "854850",
      "1593856"
    ],
    "spl_set_id": [
      "0e024b69-567c-4b40-9c3e-a2daec34256c"
    ],
    "manufacturer_name": [
      "Elite Laboratories, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:64850-556_2d33f701-8067-4a48-98cc-4e7dacaf3cc4"